Seventy-two patients with Rh erythroblastosis were treated with promethazine hydrochloride (P-HCl) during a seven-year period. Compared to the pregnancy outcome of the immediately preceding pregnancies, we have found a significant decrease in perinatal mortality and exchange transfusions. No significant toxicity from P-HCl treatment has been noted, and none of these patients developed preeclampsia.